NEWS & COMMENTS

PROHOST    FILTER

   MANAGEMENT, MANAGEMENT, MANAGEMENT

    That’s what our dear friend Orest kept repeating two days ago while referring to Hana Biosciences’ (HNAB) extraordinary out-performance in the past few months. He did not forget to remind us that he is the one who brought this firm to our attention.

Both his statements are correct and we do agree that bad management turns gold into mud. As a matter of fact we have seen it happen time and time again with firms that disappeared while having in hand state-of-the-art technologies and far-reaching products. In today’s news, we learned that Hana has completed its recently announced agreement to license products from Inex Pharmaceuticals (TSX:IEX). Hana did not lose time. It paid INEX a total of $11.5 million, consisting of cash and shares of Hana common stock. In addition, decided to pay INEX up to $30.5 million in shares of Hana common stock, contingent upon achievement of specific clinical and regulatory milestones, as well as royalties on net sales.

This licensing transaction doubled Hana's pipeline to six clinical-stage oncology compounds. The plan is there, the time table is put and clinical trials will start soon. This year.

Read more about the newly-licensed drug candidates and the press release: Hana Biosciences Completes Licensing of Three Targeted Cancer Drug Candidates from Inex Pharmaceuticals

Management, yes, is key. It is also a golden key to investors’ confidence.  

Prohost is independent publication providing information on biotech companies. Prohost does not accept compensation from companies that are featured or profiled. It is strongly recommended that any purchase or sale decisions to any of the featured companies be discussed with a financial advisor or broker prior to completing any such purchase or sale decision. All statements or expressions are the opinion of Prohost and are not meant to be a solicitation or recommendation to buy, sell, or hold securities. Investing in embryonic companies, micro-cap and growth securities is highly speculative and carries a high degree of risk. It is possible that an investor can lose all of his/her investment in this type of companies that are profiled. The information that Prohost relies on is either through the profiled company, news services, research reports, interviews, or other outside sources that Prohost believes are reliable. Prohost makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure of the profiled companies and accepts no responsibilities for inaccuracies or misleading content in any material supplied by those clients. There can be no assurance that future events relating to the profiled company will occur as anticipated. The information contained herein is provided as an information service only. Past performance of featured companies does not guarantee the future success of any currently featured or profiled company. We encourage our readers to invest carefully and read the investor information provided by the Securities and Exchange Commission ("SEC") and/or the National Association of Securities Dealers ("NASD"). We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at: http://www.sec.gov/consumer/cyberfr.htm